Search
for
Sort by
Research 21
- Cutaneous Toxicities From Transplantation-Related Medications
- Permanent chemotherapy-induced nonscarring alopecia and premature ovarian failure
- Immunosuppressive therapy in autoimmune disease — A review
- Drug eruptions in dermatology
- Modulating the stem cell niche for tissue regeneration
- Persistent Panniculitis in Dermatomyositis
- Dermatologic Adverse Events from Cancer Treatments
- Multiple skin cancers in a patient within 1 year of allogeneic haematopoietic cell transplant for chronic lymphocytic leukaemia
- Benign Cutaneous Eruptions After Transplantation
- Interferon alfa-2a in the treatment of cutaneous T cell lymphoma
- Comparison of allogeneic stem cell transplant conditioning regimens in AML, MDS and CLL
- Calcineurin-based immunosuppression in renal transplantation : focus on efficacy, the role of steroids, and the cardiovascular risk
- Permanent chemotherapy-induced alopecia after hematopoietic stem cell transplantation treated with low-dose oral minoxidil
- Cyclosporine-induced alopecia:a case report, FDA adverse event reporting system analysis and literature assessment
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Clinical Application of Development of Nonantibiotic Macrolides That Correct Inflammation-Driven Immune Dysfunction in Inflammatory Skin Diseases
- Three Cases of Alopecia Following Clinical Islet Transplantation
- Drug-induced scarring and permanent alopecia
- Hormone replacement therapy and COVID-19 outcomes in solid organ transplant recipients compared with the general population
- CAQ Corner: Basic concepts of transplant immunology
- Stem-cell therapy in dermatology – Challenges and opportunities